Injective debuts pre-IPO derivatives, distancing from Robinhood private equity tokens
Injective launches onchain pre-IPO perpetuals for companies like OpenAI, offering leveraged exposure and a decentralized alternative to Robinhood’s tokens.
Injective Protocol, a layer-1 blockchain focused on decentralized finance, is launching onchain pre-IPO perpetual markets, giving global investors access to trade synthetic versions of major private companies such as OpenAI.
The new offering allows users to take up to five times leveraged positions on private company valuations directly through Injective, a move the protocol says distinguishes it from centralized pre-IPO products offered by platforms like Robinhood.
According to Injective’s announcement on Wednesday, the Pre-IPO perpetuals are powered by onchain data sourced from Seda Protocol, which provides decentralized oracle infrastructure to bring price data onto blockchains, and Caplight, which aggregates private market pricing data for venture-backed companies.